Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Impact of ALK fusion variants and genetic profiles on prognosis in Chinese pediatric patients with ALK-positive anaplastic large cell lymphoma

Blood (2025) 146 (Supplement 1): 3526.

https://doi.org/10.1182/blood-2025-3526

Published: 2025

Journal Articles

Germline variant database and visualization platform for BMF and hematologic malignancy predisposition syndromes: BMFgenes1.0

Lili Kotmayer, Andrew Willems, Jian Wang, Karishma Gangwani, Julia Weber, Joshua Leow, Sara Lewis, Enrico Attardi, Majd Khiami, Masanori Yoshida, Damian Krzyzanowski, Barbara Kuhn, Sushree Sahoo, Xin Zhou, Marcin Wlodarski

Blood (2025) 146 (Supplement 1): 3222.

https://doi.org/10.1182/blood-2025-3222

Published: 2025

Journal Articles

Effect and mechanism of allopurinol in ALL maintenance therapy: Reducing hepatotoxicity and improving myelosuppression effect via TPMT inhibition and increased DNA-thioguanine levels

Yanping Guan, Xiao-Li Zhang, Jian Wang, Min Huang, Libin Huang, Xueding Wang, Dun-Hua Zhou

Blood (2025) 146 (Supplement 1): 6852.

https://doi.org/10.1182/blood-2025-6852

Published: 2025

Journal Articles

Clinical characteristics and treatment evaluation of T-cell lymphoblastic lymphoma in Chinese children and adolescents：a multicenter clinical study of China-net childhood lymphoma-lbl-2017

Blood (2025) 146 (Supplement 1): 7155.

https://doi.org/10.1182/blood-2025-7155

Published: 2025

Journal Articles

ALL-pharmacotyping data portal: An open-source platform for exploring genomics of leukemia drug susceptibility and resistance

Karishma Gangwani, Satoshi Yoshimura, Zhenhua Li, Robin Paul, Wenjian Yang, Congyu Lu, Jian Wang, Andrew Willems, Gavriel Matt, Edgar Sioson, Colleen Reilly, Airen Zaldivar Peraza, Aleksandar Acić, Shawn Lee, Jun J. Yang, Xin Zhou

Blood (2025) 146 (Supplement 1): 5139.

https://doi.org/10.1182/blood-2025-5139

Published: 2025

Journal Articles

Prognostic for CNS3 Control in Children with Lymphoblastic Lymphoma Treated with Chemotherapy without Cranial Irradiation:a Multicenter, China Net-Childhood Lymphoma-NHL-2017-Lbl Program

Lingzhen Wang, Ling Jin, Yonghong Zhang, Lirong Sun, Fu Li, Mincui Zheng, Yunpeng Dai, Leping Zhang, Ansheng Liu, Jian Wang, Xiaojun Yuan, Rong Liu, Xiaofan Zhu

Blood (2024) 144 (Supplement 1): 6381.

https://doi.org/10.1182/blood-2024-205097

Published: 2024

Journal Articles

The Mutational Profile and Fusion Landscape of Chinese Pediatric B-Cell Lymphoblastic Lymphoma Patients

Yang Li, Ling Jin, Ying Liu, Yueping Jia, Yunpeng Dai, Lihua Yang, Rong Liu, Lian Jiang, Zhongjin Xu, Ansheng Liu, Xiaojun Yuan, Jian Wang, Qinlong Zheng, Yonghong Zhang

Blood (2024) 144 (Supplement 1): 6237.

https://doi.org/10.1182/blood-2024-212018

Published: 2024

Journal Articles

The Emerging Landscape of the Inherited Bone Marrow Failure Syndromes in Mexico

Blood (2024) 144 (Supplement 1): 5700.

https://doi.org/10.1182/blood-2024-210523

Published: 2024

Journal Articles

NOTCH1 gene Fusions Occur Frequently in Refractory or Relapsed (R/R) T-Cell Lymphomablastic Lymphoma

Yu Xia, Kai Wang, Keyan Yang, Ling Jin, Ying Liu, Yueping Jia, Yunpeng Dai, Lihua Yang, Rong Liu, Lian Jiang, Zhongjin Xu, Ansheng Liu, Xiaojun Yuan, Jian Wang, Yonghong Zhang, Qinlong Zheng

Blood (2024) 144 (Supplement 1): 4225.

https://doi.org/10.1182/blood-2024-212203

Published: 2024

Journal Articles

BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or menin inhibitor

Blood (2024) 143 (20): 2059–2072.

https://doi.org/10.1182/blood.2023022832

Published: 2024

Includes: Supplemental data

Journal Articles

Targeted Degradation of the Wiz Transcription Factor for Gamma Globin De-Repression

Blood (2023) 142 (Supplement 1): 2.

https://doi.org/10.1182/blood-2023-179331

Published: 2023

Journal Articles

Preliminary Results of the Oral CD73 Inhibitor, Oric-533, in Relapsed/Refractory Multiple Myeloma (RRMM)

Cesar Rodriguez, Scott R. Solomon, Barry Paul, Omar Nadeem, Meenal Patel, Jian Wang, Rongda Xu, Melissa Junttila, Anneleen Daemen, Subhash Katewa, Pratik S Multani, Wilson I. Gonsalves

Blood (2023) 142 (Supplement 1): 4761.

https://doi.org/10.1182/blood-2023-173730

Published: 2023

Journal Articles

Prognostic Impact of Minimal Disseminated Disease (MDD) and Minimal Residual Disease (MRD) in Chinese Pediatric Patients with ALK-Positive Anaplastic Large Cell Lymphoma (ALCL)

Blood (2023) 142 (Supplement 1): 6088.

https://doi.org/10.1182/blood-2023-188415

Published: 2023

Journal Articles

Clinical Pathology Characteristics of 221 Pediatric Anaplastic Large Cell Lymphoma-3 Years Follow up and Experience from China Net Childhood Lymphoma(CNCL)

Blood (2023) 142 (Supplement 1): 4489.

https://doi.org/10.1182/blood-2023-188761

Published: 2023

Journal Articles

Intracerebral Hemorrhage Leads to Anemia By Disrupting Erythropoiesis and Erythromyeloblastic Islands

Shijie Zhang, Peijun Jia, Qinfeng Peng, Jiaming Cao, Yuanlin Xu, Chao Jiang, Hongtao Ji, Fuyou Guo, Yan Li, Jingxin Zhang, Huan Zhang, Jiaxin Li, Ying Zhang, Xinyang Zhao, Xuemei Chen, Jian Wang, Xiuli An

Blood (2023) 142 (Supplement 1): 3821.

https://doi.org/10.1182/blood-2023-186235

Published: 2023

Journal Articles

Clinical Features and Therapeutic Evaluation of Central Nervous System Involvement in Pediatric Anaplastic Large Cell Lymphoma

Blood (2023) 142 (Supplement 1): 1709.

https://doi.org/10.1182/blood-2023-188173

Published: 2023

Journal Articles

Safety, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Adult Patients with Primary Immune Thrombocytopenia: A Randomized, Double-Blind and Placebo-Controlled Phase 1b Study

Blood (2021) 138 (Supplement 1): 16.

https://doi.org/10.1182/blood-2021-149895

Published: 2021

Journal Articles

IL-1 Via IRAK1/4 Sustains Acute Myeloid Leukemia Stem Cells Following Treatment and Relapse

Tzu-Chieh Ho, Hiroki Kawano, Mark W. LaMere, Naxin Guo, Yu-Chiao Chiu, Jian Wang, Craig T. Jordan, Nikolay V. Dokholyan, Laura M. Calvi, Rakesh Kumar Singh, Michael W. Becker

Blood (2021) 138 (Supplement 1): 1175.

https://doi.org/10.1182/blood-2021-149903

Published: 2021

Journal Articles

Nivolumab treatment of relapsed/refractory Epstein-Barr virus–associated hemophagocytic lymphohistiocytosis in adults

Pengpeng Liu, Xiangyu Pan, Chong Chen, Ting Niu, Xiao Shuai, Jian Wang, Xuelan Chen, Jiazhuo Liu, Yong Guo, Liping Xie, Yu Wu, Yu Liu, Ting Liu

Blood (2020) 135 (11): 826–833.

https://doi.org/10.1182/blood.2019003886

Published: 2020

Includes: Supplemental data

Journal Articles

Impact of ABO Blood Group Incompatibility on Outcomes after Single-Unit Umbilical Cord Blood Transplantation for Malignant Hematological Disease

Cheng Siqi, Baolin Tang, Xiaoyu Zhu, Huilan Liu, Kaidi Song, Xiang Wan, Wen Yao, Jian Wang, Zimin Sun

Blood (2019) 134 (Supplement_1): 2055.

https://doi.org/10.1182/blood-2019-130699

Published: 2019

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Impact of ALK fusion variants and genetic profiles on prognosis in Chinese pediatric patients with ALK-positive anaplastic large cell lymphoma

Germline variant database and visualization platform for BMF and hematologic malignancy predisposition syndromes: BMFgenes1.0

Effect and mechanism of allopurinol in ALL maintenance therapy: Reducing hepatotoxicity and improving myelosuppression effect via TPMT inhibition and increased DNA-thioguanine levels

Clinical characteristics and treatment evaluation of T-cell lymphoblastic lymphoma in Chinese children and adolescents：a multicenter clinical study of China-net childhood lymphoma-lbl-2017

ALL-pharmacotyping data portal: An open-source platform for exploring genomics of leukemia drug susceptibility and resistance

Prognostic for CNS3 Control in Children with Lymphoblastic Lymphoma Treated with Chemotherapy without Cranial Irradiation:a Multicenter, China Net-Childhood Lymphoma-NHL-2017-Lbl Program

The Mutational Profile and Fusion Landscape of Chinese Pediatric B-Cell Lymphoblastic Lymphoma Patients

The Emerging Landscape of the Inherited Bone Marrow Failure Syndromes in Mexico

NOTCH1 gene Fusions Occur Frequently in Refractory or Relapsed (R/R) T-Cell Lymphomablastic Lymphoma

BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or menin inhibitor

Targeted Degradation of the Wiz Transcription Factor for Gamma Globin De-Repression

Preliminary Results of the Oral CD73 Inhibitor, Oric-533, in Relapsed/Refractory Multiple Myeloma (RRMM)

Prognostic Impact of Minimal Disseminated Disease (MDD) and Minimal Residual Disease (MRD) in Chinese Pediatric Patients with ALK-Positive Anaplastic Large Cell Lymphoma (ALCL)

Clinical Pathology Characteristics of 221 Pediatric Anaplastic Large Cell Lymphoma-3 Years Follow up and Experience from China Net Childhood Lymphoma(CNCL)

Intracerebral Hemorrhage Leads to Anemia By Disrupting Erythropoiesis and Erythromyeloblastic Islands

Clinical Features and Therapeutic Evaluation of Central Nervous System Involvement in Pediatric Anaplastic Large Cell Lymphoma

Safety, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Adult Patients with Primary Immune Thrombocytopenia: A Randomized, Double-Blind and Placebo-Controlled Phase 1b Study

IL-1 Via IRAK1/4 Sustains Acute Myeloid Leukemia Stem Cells Following Treatment and Relapse

Nivolumab treatment of relapsed/refractory Epstein-Barr virus–associated hemophagocytic lymphohistiocytosis in adults

Impact of ABO Blood Group Incompatibility on Outcomes after Single-Unit Umbilical Cord Blood Transplantation for Malignant Hematological Disease

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only